[Abstract Only] Randomized Trial: Lisinopril vs. Carvedilol vs. Placebo to Prevent Trastuzumab Cardiotoxicity in Patients with Breast Cancer
5 Jun, 2019 | 04:13h | UTCRandomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer – Journal of the American College of Cardiology (link to abstract – $ for full-text)
“In patients with HER2-positive breast cancer treated with trastuzumab, both lisinopril and carvedilol prevented cardiotoxicity in patients receiving anthracyclines.”